Numbers

The Numbers

Daqo is a balance-sheet story trading like a cash-burn story. The polysilicon cycle has wiped out earnings — revenue collapsed from $4.6B (FY22) to $665M (FY25), and operating income flipped from +$3.0B to -$270M. Yet the company still sits on $1.94B of cash with effectively zero debt and $5.9B of book equity. With the stock at $19.03 today, the market cap of roughly $1.29B is below the company's cash balance and trades at ~0.22× book — a level usually reserved for businesses the market expects to liquidate. The single number that will rerate or derate this stock is the polysilicon ASP: every $1/kg above cash cost on 200kt+ of capacity is roughly $200M of incremental EBITDA. Until that price recovers, the question isn't valuation; it's how fast the cash pile erodes.

A. Snapshot

B. Quality scorecard

The balance sheet is the only thing keeping this name investable. Take the cash away and there is nothing in the income statement worth paying for at the moment — Daqo is structurally a low-cost producer in a commodity that is currently selling below cash cost industry-wide.

C. Revenue & earnings power — 17-year view

The classic commodity cycle: ASP shock in 2020-2022 drove gross margins to 74% and net income above $1.8B; oversupply since 2023 has erased it entirely. Margins below cash cost since mid-FY24 mean the industry as a whole is losing money on every kilogram shipped.

D. The collapse, in quarters

Q1 2026 is the most surprising data point on this page: revenue of $26.7M is a roughly 95% drop from peak quarterly revenue and well below the (already depressed) Q4 2025 print of $222M. The Q1 2026 operating loss of $151M has resurrected the cash-burn story that Q3-Q4 2025 had been narrowing. This is the data point most likely driving the recent share price weakness.

E. Cash conversion — are the earnings real?

Cash conversion runs hot during good years (CFO/NI of 1.0-2.5×, helped by D&A and working capital releases) and improves the headline in bad years too — FY25 operating cash flow was positive $50M against a $216M reported net loss because $240M of D&A is non-cash. The truer signal is FCF: -$917M cumulative across FY24-FY25 even as capex was throttled from $1.2B to $173M. Capex is now running below depreciation, which protects cash but also signals that no capacity expansion is funded from current operations.

F. Capital allocation

The only meaningful return of capital came in FY23 — $486M of buybacks executed at average prices well above today's quote. Since FY24, with cash flow turning negative, management has frozen buybacks and stopped paying down debt (debt is already zero). Stock-based compensation has compressed to $56M in FY25 — manageable, but a cumulative $580M of SBC since FY18 has issued roughly 5M+ shares against a modest $616M of repurchases.

G. Balance-sheet health

This is where the bull case lives. Daqo carries no interest-bearing debt, $1.94B of cash, and $5.92B of equity against a $1.29B market cap. Book value per share has held above $63 for four consecutive years — even through two years of losses — because retained earnings from FY21-22 ($2.5B) absorbed all subsequent damage and capex was funded from operating cash. The risk: FY24 cash dropped $935M, FY25 dropped another $161M; another year of similar burn would breach $1B.

H. Valuation — now vs its own 17-year history

EV/EBITDA is meaningless here — EBITDA is currently negative and EV is currently negative. P/B and price-to-cash are the only multiples that travel through the cycle.

I. Peer comparison

DQ is uniquely positioned in the peer set: smallest revenue, deepest losses (per dollar of revenue), worst ROE — but the lowest P/B and the only company with a cash balance larger than its market cap. First Solar is the outlier on the other end: nearly $30B mkt cap on $5.2B of revenue at 29% net margins, benefiting from non-Chinese supply chain status and Inflation Reduction Act tax credits. JinkoSolar and Canadian Solar are the closest comparators on cycle exposure, but neither has Daqo's net-cash buffer. (All figures in USD; JKS revenue converted from CNY ~7.3, WCH from EUR ~1.08.)

J. The market-cap-vs-cash chart

The market is paying $0.22 per dollar of book value and $0.66 per dollar of cash. The PP&E line ($3.4B at book) gets zero credit. Even a 50% writedown of fixed assets would still leave equity at roughly $4.2B — more than 3× the current market cap.

K. Fair-value scenario

The base case anchors on the 7-year median P/B (0.63×) and assumes book value holds at current levels — both are uncertain but neither is heroic. The bear case requires book value itself to compress by a quarter, which would mean a large polysilicon-asset impairment plus continued operating losses. The bull case requires polysilicon ASPs to materially recover, which industry forecasts suggest is more a 2027-2028 question than a 2026 one.

What the numbers say

The numbers confirm that Daqo is one of the lowest-cost polysilicon producers with a fortress balance sheet: $1.94B cash, no debt, current ratio 5.4×, and book value that has held flat through two years of operating losses. The numbers contradict the bear narrative that Daqo is going broke — even at the FY24 cash-burn rate of $935M, the company has more than two years of runway, and the burn has materially decelerated to $161M in FY25 with operating cash flow turning positive again. What to watch is the polysilicon ASP and Q1 2026's revenue collapse to $26.7M — if that quarter was inventory-cycle noise (Chinese New Year, customer destocking) the FY25 stabilization story holds; if it represents a step-function decline in demand, the runway compresses fast and the cash-vs-market-cap arbitrage will close the wrong way.